Detlef K Bartsch is Professor and Chairman of the Department of Visceral, Thoracic and Vascular Surgery at the Philipps-University Marburg, Germany. He has 25 years’ experience in the field of endocrine and pancreatic surgery, especially in GEP-NETs and MEN-1. He is the surgical partner of the ENETS Center of Excellence (CoE) at the Marburg University Hospital. He was President of the German Society of Endocrine Surgeons from 2014 until 2017. Professor Bartsch has published more than 280 publications in peer-reviewed journals and serves on the ENETS Executive Committee.

Eric Baudin, Associate Professor, is Head of the Endocrine Oncology Unit at the Institut Gustave Roussy Unit, Villejuif, France. His research areas include the diagnosis, treatment, and follow-up of patients with endocrine tumors. Dr Baudin has served on the Advisory Board to ENETS, ENSAT and ESMO. He has published widely on the management of endocrine tumors. He is head of coordination for the French Endocrine Tumor Network (from 2019 to date) and is currently President of the French Group of Endocrine Tumors (2017 - 2019). He became a member of the ENETS Executive Committee in 2020.

Anne Couvelard is Professor of Pathology at Université de Paris and Head of the Department of Pathology in Beaujon and Bichat Hospitals, Paris, France. Her main topics of research are pancreatic and neuroendocrine oncogenesis, pathology and molecular markers. She is a member of ENETS since 2004, joined the ENETS Advisory Board member in 2015, and became an ENETS Executive Committee member in 2018. She is a member of the French pathological network for neuroendocrine tumors « TENpath » since 2011, and was involved in the 2017 and 2019 WHO classifications of tumors of endocrine organs and of the digestive system. She has published more than 300 papers in international journals and is a reviewer for journal in the fields of pathology, oncology gastroenterology and endocrinology.

Nicola Fazio is the Director of the Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors and Director of the programme in Digestive and Neuroendocrine Tumors at the European Institute of Oncology (IEO, IRCCS) in Milan, Italy, since 1995. Since 2015 he is head of the IEO ENETS Center of Excellence for GEP NETs. He served as ESMO Faculty Coordinator for Neuroendocrine, Endocrine and CUP from 2016 - 2019. He was Chair of the ESMO NEN Preceptorship from 2017 - 2018 and was invited to be Chair again in 2019. He was also asked to be chair of the ESMO NEN Advanced Course in 2019. Since 2013, he is Coordinator of the Italian (AIOM/ITANET) neuroendocrine neoplasms guidelines. Dr Fazio is an ENETS member, was Advisory Board Chairman since 2019 and member of the ENETS Advisory Board since 2015. Since 2020 he is member of the ENETS Executive Committee. He graduated in 1988 from the Faculty of Medicine and Surgery at the University of L’Aquila, Italy. In 1993, he specialised in internal medicine and in 2003, in oncology. In 2013, he gained a PhD in Digestive Oncology.

Rocio Garcia-Carbonero is a Consultant in medical oncology at Hospital Universitario Doce de Octubre, Madrid, Spain, where she leads the GI and NE Oncology Unit. She is also an Associate Professor at Universidad Complutense in Madrid (UCM), Spain. She is a member of the ENETS Executive Committee, a member of the ESMO NET Track Scientific Committee, and the Past Chair of the Spanish National Cooperative Group of NETs (GETNE) (2011-2019). Professor Garcia-Carbonero is actively involved in clinical and translational research with a particular focus on the development of new drugs in GI and NENs. She also devotes a lot of time to continued medical education. She is a member of the ESMO Oncology PRO working group and the director of the GETNE UCM Master in NENs.

Dermot O’Toole is Professor of Gastroenterology and Clinical Medicine at Trinity College Dublin (TCD, The University of Dublin) and Consultant Gastroenterologist at St James’s and St. Vincent’s University Hospitals Dublin, Ireland. He graduated from TCD and has postgraduate degrees from TCD and the Universities of Paris and Angers. His major research interests include gastrointestinal cancer biology, especially in neuroendocrine tumor (NET)-related diseases and early GI neoplasia (Barrett’s oesophagus, gastric and colorectal cancers). Professor O’Toole is Clinical Lead for the national NET group. He has served on the Executive Committee of the European Neuroendocrine Tumor Society (ENETS) and is current Vice-Chairman of ENETS, helping to develop guideline papers and standards of care initiatives in the field of NET. He is Past Chair of the ENETS-driven European Centers of Excellence programme. He has been involved in many national and international research activities in GI oncology and is a member of several professional bodies in Europe and North America, serving as advisor to national health-care projects as well as patient advocacy groups.

Marianne Pavel is a Senior Physician and Chair of Endocrinology at the Friedrich-Alexander University of Erlangen, Germany. She is also Head of the NET Center. Her major focus for the last 20 years is on neuroendocrine tumors. She is first author of the 2012 and the updated 2016 “ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary”. Board certified as a specialist in internal medicine in 2000, and endocrinology/diabetes in 2001, she was appointed as Vice Head of the Division of Endocrinology and Metabolism at the Friedrich-Alexander University Erlangen in 2001. She took a position as an Assistant Director at the Charité University Hospital in Berlin in 2007 and was conferred a Professorship for NET Disease at the Charité in 2010. She has conducted numerous clinical trials in the field of NET and supports the activities of ENETS since 2005. In 2009, under her guidance, the NET Center at the Charité was certified as one of the first ENETS Centers of Excellence. She is a member of the ENETS Executive Committee since April 2014 and its Chair since 2020.

John Ramage is a Consultant Physician in Gastroenterology and Hepatology, Honorary Consultant Physician at the Institute of Liver Studies, King’s College Hospital and Lead Clinician for King’s Health Partners NET Centre which includes King’s, Guys and St Thomas’s, Kent Oncology Centre and Hampshire Hospitals, UK. Professor Ramage was previously Research Director at Hampshire Hospitals Foundation Trust and is Head Clinician for the Hampshire Collaboration for Health Research and Education. Professor Ramage trained at Portsmouth, Brighton and King’s College hospitals. He is past Treasurer and immediate past Chair of the UK and Ireland Neuroendocrine Tumour Society (UKI NETS). He is a member of the EORTC Quality of Life Group, through which he pursues research into quality of life in cancers. His main research interest is in quality of life and symptoms scores in neuroendocrine tumors of the small bowel and liver.  He has written more than 100 peer-reviewed publications and was the corresponding author of the UK guidelines for NETs.  He now serves on the Executive Board of ENETS.

Eva Tiensuu Janson serves as a Senior Consultant at the ENETS CoE in Uppsala. She is a Professor of Medicine at the Department of Medical Sciences, Uppsala University, Sweden. Since 2020 she is Deputy Vice-rector of the disciplinary domain of Medicine and Pharmacy at Uppsala University. Professor Janson is Chair of the Nordic Neuroendocrine Tumor Group and member of the Executive Committee of the ENETS. Her translational research has resulted in more than 100 publications in peer-reviewed journals; she focuses on the genetics and tumor biology of neuroendocrine tumors. She chairs the Swedish national registry as well as the committee for the national caring programme for gastrointestinal neuroendocrine tumors.

Christos Toumpanakis, MD, PhD, FRCP, AGAF, FEBGH, is a Consultant in Gastroenterology & NET at the NET Unit (ENETS Center of Excellence) of Royal Free Hospital, London, UK. He is also an Honorary Associate Professor at University College of London and has been awarded “Top-Teacher” of the Year seven times. He is the Chair of ENETS Advisory Board, Co-chair of ENETS Postgraduate Course, co-editor of the ENETS CME programme and co-author of UKINETS & ENETS Guidelines. He has presented at several national and international conferences and published many original papers and reviews. He  leads a NET clinical research group and his main research interests include novel NET biomarkers, molecular imaging in NETs, and carcinoid heart disease.